Nairo Quintana again denies using tramadol as CAS confirms Tour de France disqualification

 Nairo Quintana (Arkea-Samsic) during stage 18 of the 2022 Tour de France
Nairo Quintana (Arkea-Samsic) during stage 18 of the 2022 Tour de France (Image credit: Michael Steele/Getty Images)

Nairo Quintana has continued to deny wrongdoing in his initial response to news that the Court of Arbitration of Sport had upheld the UCI’s decision to disqualify him from the 2022 Tour de France following his positive tests for the painkiller tramadol during the race.

The CAS verdict was announced on Thursday morning, ending Quintana’s hopes of having his 6th place finish at this year’s Tour restored. Quintana will not face a ban, as a first positive test for tramadol is considered an offence under the UCI Medical Rules but it does not constitute an anti-doping rule violation.

Thank you for reading 5 articles in the past 30 days*

Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read any 5 articles for free in each 30-day period, this automatically resets

After your trial you will be billed £4.99 $7.99 €5.99 per month, cancel anytime. Or sign up for one year for just £49 $79 €59

Join now for unlimited access

Try your first month for just £1 / $1 / €1

Barry Ryan
Head of Features

Barry Ryan is Head of Features at Cyclingnews. He has covered professional cycling since 2010, reporting from the Tour de France, Giro d’Italia and events from Argentina to Japan. His writing has appeared in The Independent, Procycling and Cycling Plus. He is the author of The Ascent: Sean Kelly, Stephen Roche and the Rise of Irish Cycling’s Golden Generation, published by Gill Books.